7,572 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by NorthCrest Asset Manangement LLC

NorthCrest Asset Manangement LLC bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,572 shares of the company’s stock, valued at approximately $651,000.

A number of other hedge funds also recently bought and sold shares of PBH. Kestra Investment Management LLC bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $27,000. CIBC Private Wealth Group LLC boosted its holdings in Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock valued at $34,000 after acquiring an additional 152 shares during the period. Headlands Technologies LLC bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $40,000. McIlrath & Eck LLC boosted its holdings in Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock valued at $75,000 after acquiring an additional 154 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $93,000. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $83.84 on Friday. Prestige Consumer Healthcare Inc. has a 12-month low of $64.03 and a 12-month high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $4.14 billion, a PE ratio of 19.63, a price-to-earnings-growth ratio of 2.69 and a beta of 0.45. The firm has a 50-day moving average price of $83.77 and a 200 day moving average price of $82.55.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The firm had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the prior year, the business posted $1.02 earnings per share. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 17th. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a “hold” rating in a research report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.